BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 12420087)

  • 21. Ryanodine receptor channelopathies.
    Benkusky NA; Farrell EF; Valdivia HH
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1280-5. PubMed ID: 15336975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation spectrum and health status in skeletal muscle channelopathies in Japan.
    Sasaki R; Nakaza M; Furuta M; Fujino H; Kubota T; Takahashi MP
    Neuromuscul Disord; 2020 Jul; 30(7):546-553. PubMed ID: 32660787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of ion-regulatory membrane proteins of excitation-contraction coupling and relaxation in inherited muscle diseases.
    Froemming GR; Ohlendieck K
    Front Biosci; 2001 Jan; 6():D65-74. PubMed ID: 11145921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness.
    Hayward LJ; Kim JS; Lee MY; Zhou H; Kim JW; Misra K; Salajegheh M; Wu FF; Matsuda C; Reid V; Cros D; Hoffman EP; Renaud JM; Cannon SC; Brown RH
    J Clin Invest; 2008 Apr; 118(4):1437-49. PubMed ID: 18317596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Channelopathies of skeletal muscle excitability.
    Cannon SC
    Compr Physiol; 2015 Apr; 5(2):761-90. PubMed ID: 25880512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy in myotonic disorders and in muscle channelopathies.
    Meola G; Sansone V
    Neurol Sci; 2000; 21(5 Suppl):S953-61. PubMed ID: 11382195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Channels active in the excitability of nerves and skeletal muscles across the neuromuscular junction: basic function and pathophysiology.
    Goodman BE
    Adv Physiol Educ; 2008 Jun; 32(2):127-35. PubMed ID: 18539851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle biopsy and cell cultures: potential diagnostic tools in hereditary skeletal muscle channelopathies.
    Meola G; Sansone V; Rotondo G; Mancinelli E
    Eur J Histochem; 2003; 47(1):17-28. PubMed ID: 12685554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscle channelopathies.
    Statland J; Phillips L; Trivedi JR
    Neurol Clin; 2014 Aug; 32(3):801-15, x. PubMed ID: 25037091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voltage-sensor mutations in channelopathies of skeletal muscle.
    Cannon SC
    J Physiol; 2010 Jun; 588(Pt 11):1887-95. PubMed ID: 20156847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ion-channel related muscular diseases].
    Fontaine B
    Rev Med Interne; 1999 Sep; 20(9):774-80. PubMed ID: 10522299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Channelopathy].
    Okamoto K; Ikeda Y
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1226-8. PubMed ID: 12235844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cold extends electromyography distinction between ion channel mutations causing myotonia.
    Fournier E; Viala K; Gervais H; Sternberg D; Arzel-Hézode M; Laforêt P; Eymard B; Tabti N; Willer JC; Vial C; Fontaine B
    Ann Neurol; 2006 Sep; 60(3):356-65. PubMed ID: 16786525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiology and molecular pharmacology of muscle channelopathies.
    Jurkat-Rott K; Lehmann-Horn F
    Rev Neurol (Paris); 2004 May; 160(5 Pt 2):S43-8. PubMed ID: 15269660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myocyte sarcolemmal and cytoskeleton proteins in inherited muscular diseases].
    Carpén O
    Duodecim; 2003; 119(3):179-86. PubMed ID: 12650015
    [No Abstract]   [Full Text] [Related]  

  • 36. Core myopathies and risk of malignant hyperthermia.
    Klingler W; Rueffert H; Lehmann-Horn F; Girard T; Hopkins PM
    Anesth Analg; 2009 Oct; 109(4):1167-73. PubMed ID: 19762745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Myotonia and channelopathy].
    Kurihara T
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1219-21. PubMed ID: 10791081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ion channel mutations and diseases of skeletal muscle.
    Barchi RL
    Neurobiol Dis; 1997; 4(3-4):254-64. PubMed ID: 9361302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered fast and slow inactivation of the N440K Nav1.4 mutant in a periodic paralysis syndrome.
    Lossin C; Nam TS; Shahangian S; Rogawski MA; Choi SY; Kim MK; Sunwoo IN
    Neurology; 2012 Sep; 79(10):1033-40. PubMed ID: 22914841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.
    Lehmann-Horn F; Jurkat-Rott K; Rüdel R;
    Acta Myol; 2008 Dec; 27(3):98-113. PubMed ID: 19472919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.